Učitavanje...

Brivaracetam: a novel antiepileptic drug for focal-onset seizures

Brivaracetam (BRV), the n-propyl analogue of levetiracetam (LEV), is the latest antiepileptic drug (AED) to be licensed in Europe and the USA for the adjunctive treatment of focal-onset seizures with or without secondary generalization in patients aged 16 years or older. Like LEV, BRV binds to synap...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Neurol Disord
Glavni autori: Stephen, Linda J., Brodie, Martin J.
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784556/
https://ncbi.nlm.nih.gov/pubmed/29399049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285617742081
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!